Det kan være hensiktsmessig med ensartede besvarelser fra patologiavdelinger i hele landet. Dette vil kunne bidra til å få med alle faktorer som er viktige for stadieinndeling og for videre behandling. Se forslag til mal ved besvarelse av reseksjonspreparater med tykk- og endetarmskreft i vedlegg til dette kapittelet.
19. Patologi
19. 1. Makrohåndtering
19. 2. Mikrohåndtering
19. 3. UICC: TNM-klassifisering og stadieinndeling
19. 4. Histologisk gradering
19. 5. Lymfeknuter
19. 6. Histopatologisk evaluering av tumorrespons
19. 7. Polypper med adenocarcinom i tykk og endetarm
19. 8. Mal for tykktarmskreft
19. 9. Mal for endetarmskreft
19. 10. Tester for Lynch syndrome
19. 11. Molekylærpatologisk undersøkelse
19. 12. Spesifikt om immunhistokjemi (IHK)
19. 13. Spesifikt om molekylære analyser
19. 14. Prøvetakning og besvarelse av molekylære analyser
Abrha, A., Shukla, N. D., Hodan, R., Longacre, T., Raghavan, S., Pritchard, C. C., Fisher, G., Ford, J., & Haraldsdottir, S. (2020). Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at Stanford. JNCI cancer spectrum, 4(5), pkaa054.
Barel, F., Cariou, M., Saliou, P., Kermarrec, T., Auffret, A., Samaison, L., Bourhis, A., Badic, B., ... Uguen, A. (2019). Histopathological factors help to predict lymph node metastases more efficiently than extra-nodal recurrences in submucosa invading pT1 colorectal cancer. Scientific Reports, 9(1), 8342.
Beaton, C., Twine, C. P., Williams, G. L., & Radcliffe, A. G. (2013). Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer. Colorectal Disease, 15(7), 788-97.
Bentzen, S. M., Balslev, I., Pedersen, M., Teglbjaerg, P. S., Hanberg-Sorensen, F., Bone, J., Jacobsen, N. O., Sell, A., ... et al. (1992). Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. British Journal of Cancer, 65(1), 102-7.
Betge, J., Pollheimer, M. J., Lindtner, R. A., Kornprat, P., Schlemmer, A., Rehak, P., Vieth, M., Hoefler, G., & Langner, C. (2012). Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer, 118(3), 628-38.
Bosch, S. L., Teerenstra, S., de Wilt, J. H., Cunningham, C., & Nagtegaal, I. D. (2013). Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions. Endoscopy, 45(10), 827-34.
Brown, I., Zammit, A. P., Bettington, M., Cooper, C., Gill, A. J., Agoston, A., & Odze, R. (2023). Pathological features associated with metastasis in patients with early invasive (pT1) colorectal carcinoma in colorectal polyps. Histopathology, 83(4), 591-606.
Burgart, L. J., Shi, C., Berho, M. E., Driman, D. K., Fitzgibbons, P., Frankel, W. L., ... Hill, K. A. (2020). Protocol for the Examination of Excisional Biopsy Specimens From Patients With Primary Carcinoma of the Colon and Rectum (Version 4.1.0.0). Northfield, Illinois: College of American Pathologists. Hentet fra https://documents.cap.org/protocols/cp-gilower-colonrectum-biopsy-20-4100.pdf
Caputo, D., Caricato, M., La Vaccara, V., Taffon, C., Capolupo, G. T., & Coppola, R. (2014). T1 colorectal cancer: poor histological grading is predictive of lymph-node metastases. International Journal of Surgery (London, England), 12(3), 209-12.
Cercek, A., Lumish, M., Sinopoli, J., Weiss, J., Shia, J., Lamendola-Essel, M., El Dika, I. H., Segal, N., ... Diaz, L. A. ,. J. (2022). PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer. New England Journal of Medicine, 386(25), 2363-2376.
Cervantes, A., Adam, R., Roselló, S., Arnold, D., Normanno, N., Taïeb, J., Seligmann, J., De Baere, T., ... Martinelli, E. (2023). Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology, 34(1), 10-32.
Chalabi, M., Verschoor, Y. L., van den Berg, J., Sikorska, K., Beets, G., Lent, A. V., Grootscholten, M. C., Aalbers, A., ... Haanen, J. B. A. G. (2022). LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study. Annals of Oncology, 33(Suppl 7), S1389.
Chalabi, M., Fanchi, L. F., Dijkstra, K. K., Van den Berg, J. G., Aalbers, A. G., Sikorska, K., Lopez-Yurda, M., Grootscholten, C., ... Haanen, J. B. (2020). Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nature Medicine, 26(4), 566-576.
Haddad, T. S., Lugli, A., Aherne, S., Barresi, V., Terris, B., Bokhorst, J. M., Brockmoeller, S. F., Cuatrecasas, M., ... Nagtegaal, I. D. (2021). Improving tumor budding reporting in colorectal cancer: a Delphi consensus study. Virchows Archiv, 479(3), 459-469.
Hagemann, I. S., Bridge, J. A., Tafe, L. J., Hameed, M. R., Moncur, J. T., Bellizzi, A. M., Dolan, M., Vasalos, P., ... Yemelyanova, A. (2023). Current Laboratory Testing Practices for Assessment of ERBB2/HER2 in Endometrial Serous Carcinoma and Colorectal Carcinoma. Archives of Pathology and Laboratory Medicine, 147(10), 1148-1157.
Haggitt, R. C., Glotzbach, R. E., Soffer, E. E., & Wruble, L. D. (1985). Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology, 89(2), 328-36.
Haugland, H. K., Casati, B., Dorum, L. M., & Bjugn, R. (2011). Template reporting matters--a nationwide study on histopathology reporting on colorectal carcinoma resections. Human Pathology, 42(1), 36-40.
Helse Midt-Norge RHF, Helse Nord RHF, Helse Sør-Øst RHF, Helse Vest RHF (2026). Beslutningsforum for nye metoder: Innkalling og saksdokumenter (16.03.2026, 08:00-09:30, Grev Wedels plass). Stjørdal: Helse Midt-Norge. Hentet fra https://www.nyemetoder.no/49597e/contentassets/1deaee85578f4fc386b34ddd596e593e/offentlige-sakspapirer-beslutningsforum-16.-mars-2026.pdf
Imai, Y., Otake, Y., Tamachi, T., Yamane, T., Shimao, H., Sugihara, S., & Ichinose, M. (2025). Depth of submucosal invasion vs. Haggitt level as prognostic predictors of pedunculated‑type early‑stage colorectal cancer removed by endoscopic resection. Medicine International, 5(2), 18.
Japanese Society for Cancer of the Colon and Rectum (2019). Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication]. Journal of the anus, rectum and colon, 3(4), 175-195.
Kajiwara, Y., Oka, S., Tanaka, S., Nakamura, T., Saito, S., Fukunaga, Y., Takamatsu, M., Kawachi, H., ... Ueno, H. (2023). Nomogram as a novel predictive tool for lymph node metastasis in T1 colorectal cancer treated with endoscopic resection: a nationwide, multicenter study. Gastrointestinal Endoscopy, 97(6), 1119-1128.e5.
Katballe, N., Christensen, M., Wikman, F. P., Ørntoft, T. F., & Laurberg, S. (2002). Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients. Gut, 50(1), 43-51.
Koren, R., Siegal, A., Klein, B., Halpern, M., Kyzer, S., Veltman, V., & Gal, R. (1997). Lymph node-revealing solution: simple new method for detecting minute lymph nodes in colon carcinoma. Diseases of the Colon and Rectum, 40(4), 407-10.
Leijssen, L. G. J., Dinaux, A. M., Amri, R., Taylor, M. S., Deshpande, V., Bordeianou, L. G., Kunitake, H., & Berger, D. L. (2019). Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes. Journal of Surgical Oncology, 119(6), 749-757.
Liebig, C., Ayala, G., Wilks, J., Verstovsek, G., Liu, H., Agarwal, N., Berger, D. H., & Albo, D. (2009). Perineural invasion is an independent predictor of outcome in colorectal cancer. Journal of Clinical Oncology, 27(31), 5131-7.
Loughrey, M. B., Arends, M., Brown, I., Burgart, L. J., Cunningham, C., Flejou, J. F., ... Kakar, S. (2020). Colorectal Cancer Histopathology Reporting Guide (1 utg.) Sydney: International Collaboration on Cancer Reporting. Hentet fra https://www.iccr-cancer.org/wp-content/uploads/2023/08/ICCR-Colorectal-1st-edn-v1.0-bookmark.pdf
Loughrey, M. B., Kent, O., Moore, M., Coghlin, C., Kelly, P., McVeigh, G., & Coleman, H. G. (2020). Impact on colorectal cancer pathology reporting practice of migration from TNM 5 to TNM 8. Histopathology, 77(2), 210-222.
Loughrey, M. B., Quirke, P., Shepherd, N. A. (2023). Standards and datasets for reporting cancers: dataset for histopathological reporting of colorectal cancer (5 utg.) London: The Royal College of Pathologists. Hentet fra https://www.rcpath.org/static/c8b61ba0-ae3f-43f1-85ffd3ab9f17cfe6/c19a5cd7-3485-44c2-b5e1c87154830582/G049-Dataset-for-histopathological-reporting-of-colorectal-cancer.pdf
Lugli, A., Kirsch, R., Ajioka, Y., Bosman, F., Cathomas, G., Dawson, H., El Zimaity, H., Flejou, J. F., ... Quirke, P. (2017). Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Modern Pathology, 30(9), 1299-1311.
Martling, A., Hed Myrberg, I., Nilbert, M., Grönberg, H., Granath, F., Eklund, M., Öresland, T., Iversen, L. H., ... Lindberg, J. (2025). Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer. New England Journal of Medicine, 393(11), 1051-1064.
Meric-Bernstam, F., Hurwitz, H., Raghav, K. P. S., McWilliams, R. R., Fakih, M., VanderWalde, A., Swanton, C., Kurzrock, R., ... Hainsworth, J. (2019). Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study. Lancet Oncology, 20(4), 518-530.
Nagtegaal, I. D., Knijn, N., Hugen, N., Marshall, H. C., Sugihara, K., Tot, T., Ueno, H., & Quirke, P. (2017). Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis. Journal of Clinical Oncology, 35(10), 1119-1127.
Nakadoi, K., Tanaka, S., Kanao, H., Terasaki, M., Takata, S., Oka, S., Yoshida, S., Arihiro, K., & Chayama, K. (2012). Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection. Journal of Gastroenterology and Hepatology, 27(6), 1057-62.
Navarro Sanchez, J. M., Finkelman, B. S., Tyburski, H., Turner, B. M., Moisini, I., Katerji, H., Varghese, S., Wang, X., ... Zhang, H. (2024). Performance of HER2 DAKO HercepTest and Ventana 4B5 immunohistochemical assays on detecting HER2 gene-amplification in uterine serous carcinomas. Human Pathology, 148, 51-59.
Newell, K. J., Sawka, B. W., Rudrick, B. F., & Driman, D. K. (2001). GEWF solution. Archives of Pathology and Laboratory Medicine, 125(5), 642-5.
NICE (2017). Flowchart showing molecular testing strategies for Lynch syndrome in people with colorectal cancer. I: Molecular testing strategies for Lynch syndrome in people with colorectal cancer (HealthTech guidance Reference number: HTG430). Manchester og London: National Institute for Health and Care Excellence. Hentet fra https://www.nice.org.uk/guidance/htg430/resources/testing-strategies-flowchart-4367005453
Norderval, S., Solstad Ø, B., Hermansen, M., & Steigen, S. E. (2016). Increased lymph node retrieval decreases adjuvant chemotherapy rate for stage II colon cancer. Scandinavian Journal of Gastroenterology, 51(8), 949-55.
Papke, D. J. ,. J., Yurgelun, M. B., Noffsinger, A. E., Turner, K. O., Genta, R. M., & Redston, M. (2022). Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas. New England Journal of Medicine, 387(18), 1714-1716.
Public Health England (2017). NHS Bowel Cancer Screening Programme. Guidance on reporting lesions London: Public Health England.
Rosty, C., Brown, I., Cooper, H., Dekker, E., Driman, D. K., Gonzalez, R. S., ... Hewett, D. G. (2020). Colorectal Excisional Biopsy (Polypectomy) Histopathology Reporting Guide Sydney: International Collaboration on Cancer Reporting. Hentet fra https://www.iccr-cancer.org/datasets/published-datasets/digestive-tract/colorectal-polypectomy/
Rüschoff, J., Friedrich, M., Nagelmeier, I., Kirchner, M., Andresen, L. M., Salomon, K., Portier, B., Sredni, S. T., ... Viale, G. (2022). Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status. Virchows Archiv, 481(5), 685-694.
Segnan, N., Patnick, J., von Karsa, L. (2010). European guidelines for quality assurance in colorectal cancer screening and diagnosis. Publication Office of the European Union.
Sepulveda, A. R., Hamilton, S. R., Allegra, C. J., Grody, W., Cushman-Vokoun, A. M., Funkhouser, W. K., Kopetz, S. E., Lieu, C., ... Nowak, J. A. (2017). Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. Journal of Oncology Practice, 13(5), 333-337.
Sinicrope, F. A., & Sargent, D. J. (2012). Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clinical Cancer Research, 18(6), 1506-12.
Smith, K. D., Tan, D., Das, P., Chang, G. J., Kattepogu, K., Feig, B. W., Skibber, J. M., & Rodriguez-Bigas, M. A. (2010). Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Annals of Surgery, 251(2), 261-4.
Sobin, L. H., Gospodarowicz, M., Wittekind, C. (2016). TNM: classification of malignant tumors. Wiley-Blackwell.
Tasi, C. K., Chen, C. Y., Liu, C. Y., & Wu, Y. Y. (2012). Reliability and effectiveness of GEWF solution in the identification of lymph nodes in specimens of colorectal carcinoma. International Journal of Surgical Pathology, 20(6), 589-95.
Valtorta, E., Martino, C., Sartore-Bianchi, A., Penaullt-Llorca, F., Viale, G., Risio, M., Rugge, M., Grigioni, W., ... Gambacorta, M. (2015). Assessment of a HER2 scoring system for colorectal cancer: results from a validation study. Modern Pathology, 28(11), 1481-91.
Van Cutsem, E., Cervantes, A., Nordlinger, B., & Arnold, D. (2014). Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 25 Suppl 3, iii1-9. Erratum i: Ann Oncol 2015;26(Suppl 5):v174-7.
WHO Classification of Tumorous Editorial Board (2019). Digestive System Tumours. International Agency for Reasearch on Cancer.
WHO Classification of Tumorous Editorial Board Digestive System Tumours (Beta version ahead of print). [nettdokument]. (WHO Classification of Tumours, Volume 1). Lyon: International Agency for Reasearch on Cancer. Hentet 2026 fra https://tumourclassification.iarc.who.int/welcome/
Wijesuriya, R. E., Deen, K. I., Hewavisenthi, J., Balawardana, J., & Perera, M. (2005). Neoadjuvant therapy for rectal cancer down-stages the tumor but reduces lymph node harvest significantly. Surgery Today, 35(6), 442-5.
Zwager, L. W., Bastiaansen, B. A. J., Montazeri, N. S. M., Hompes, R., Barresi, V., Ichimasa, K., Kawachi, H., Machado, I., ... Dekker, E. (2022). Deep Submucosal Invasion Is Not an Independent Risk Factor for Lymph Node Metastasis in T1 Colorectal Cancer: A Meta-Analysis. Gastroenterology, 163(1), 174-189.
Siste faglige endring: 12. august 2026